STOCK TITAN

180 Degree Capital Faces 5.3 % Activist Push Ahead of Sept 15 Vote

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13D/A

Rhea-AI Filing Summary

Amendment No. 1 to Schedule 13D reveals that a newly consolidated activist group—comprising Marlton Partners, ATG Fund II, related management entities, and three individuals—now reports beneficial ownership of 528,901 TURN shares (≈ 5.3 % of shares outstanding). The holdings are split among Marlton Partners (1.7 %), ATG Fund II (3.0 %), Gabriel D. Gliksberg (0.5 %) and Aaron T. Morris (0.1 %). The group has invested roughly US $1.85 million in aggregate, financed with working capital and personal funds.

The filing escalates the group’s activism: on 30 Jun 2025 Marlton Partners submitted an update & resubmission letter reaffirming nominations of James C. Elbaor, Gabriel D. Gliksberg and Aaron T. Morris and adding Andrew M. Greenberg for election to 180 Degree Capital’s board at a special shareholder meeting on 15 Sep 2025. To coordinate the proxy effort the parties executed an Amended & Restated Group Agreement (7 Jul 2025) that supersedes the December 2024 pact and assigns expense responsibility to Marlton.

No reporting person has faced criminal or civil securities violations in the past five years. The group expressly disclaims beneficial ownership of shares not directly held, but may be deemed a Section 13(d) “group.”

Key takeaways for investors:

  • Activist stake meets the 5 % threshold, signalling intent to influence strategy and governance.
  • Four-person slate could shift board composition if the proxy campaign succeeds, creating a potential value-creation catalyst.
  • Ownership remains relatively small, which may limit influence absent broader shareholder support.
  • Next decisive date is the 15 Sep 2025 special meeting; expect heightened engagement and possible short-term share-price volatility.

Positive

  • Coordinated activist campaign may catalyse strategic or operational improvements if nominees gain board seats.
  • Experienced nominee Andrew M. Greenberg adds investment expertise that could benefit capital-allocation decisions.
  • Clear timeline with a 15 Sep 2025 special meeting provides investors a near-term catalyst and visibility.

Negative

  • Stake is only 5.3 %, limiting leverage unless other investors align with the activists.
  • Potential proxy contest costs and management distraction could weigh on near-term profitability.
  • Governance uncertainty may introduce share-price volatility ahead of the special meeting.

Insights

TL;DR: 5.3 % activist stake, four-director slate, moderate but credible governance pressure.

The filing formalises a cross-fund coalition led by Marlton Partners and ATG Fund II. Although the absolute holding is modest, the Schedule 13D signals an intention to run a contested election, a tactic that has historically prompted strategic reviews or buybacks at TURN. Marlton will underwrite expenses, suggesting commitment and financial capacity to mount a full proxy fight. The addition of Andrew Greenberg, with deep asset-management background, strengthens the slate’s perceived legitimacy. However, without support from larger shareholders, influence remains uncertain. Net impact: potentially constructive but contingent on broader shareholder sentiment and management response.

TL;DR: New group agreement and board nominations raise governance stakes but stake size limits leverage.

The amended filing clarifies legal coordination via the A&R Group Agreement—important for SEC compliance and cost allocation. By nominating four directors, the group seeks near-majority presence on a five-member board (TURN currently has five seats), indicating a push for substantive strategic change. The 15 Sep meeting date crystallises a tight timeline for solicitation materials. Governance risk for existing directors increases, yet litigation risk appears low given clean legal histories. Shareholders should monitor management’s counter-measures, including potential settlement or board expansion. Overall impact is material to corporate control but not yet determinative.






If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D


Marlton Partners, L.P.
Signature:/s/ James C. Elbaor
Name/Title:James C. Elbaor, Managing Member of Marlton, LLC, Investment Manager
Date:07/01/2025
Marlton, LLC
Signature:/s/ James C. Elbaor
Name/Title:James C. Elbaor, Managing Member
Date:07/01/2025
Elbaor James C.
Signature:/s/ James C. Elbaor
Name/Title:James C. Elbaor
Date:07/01/2025
ATG Fund II LLC
Signature:/s/ Gabriel D. Gliksberg
Name/Title:Gabriel D. Gliksberg, Managing Member of ATG Capital Management, LLC, Managing Member
Date:07/01/2025
ATG Capital Management, LLC
Signature:/s/ Gabriel D. Gliksberg
Name/Title:Gabriel D. Gliksberg, Managing Member
Date:07/01/2025
Gabriel D. Gliksberg
Signature:/s/ Gabriel D. Gliksberg
Name/Title:Gabriel D. Gliksberg, Managing Member
Date:07/01/2025
Aaron T. Morris
Signature:/s/ Aaron T. Morris
Name/Title:Aaron T. Morris
Date:07/01/2025

FAQ

How much of 180 Degree Capital (TURN) stock does the activist group now own?

Approximately 528,901 shares, or 5.3 % of outstanding common stock.

Who are the new board nominees disclosed in the Schedule 13D/A for TURN?

The group is nominating James C. Elbaor, Gabriel D. Gliksberg, Aaron T. Morris and Andrew M. Greenberg.

When will TURN shareholders vote on the activist slate?

A special shareholder meeting is set for 15 September 2025.

What is the aggregate purchase cost of the activist group’s TURN shares?

Roughly US $1.85 million based on disclosed purchase prices.

What agreement governs coordination among the reporting persons?

An Amended & Restated Group Agreement dated 1 July 2025, with expenses borne by Marlton.